Valuation: RushNet, Inc.

Market Cap 1.23Cr 1.06Cr 1Cr 90.98L 1.71Cr 117.55Cr 1.72Cr 12Cr 4.62Cr 60Cr 4.61Cr 4.5Cr 189.59Cr P/E 2020
13.3x
P/E 2021 55x
Enterprise Value 1.82Cr 1.58Cr 1.49Cr 1.35Cr 2.53Cr 174.38Cr 2.55Cr 18Cr 6.85Cr 88Cr 6.83Cr 6.68Cr 281.23Cr EV / Sales 2020
2.75x
EV / Sales 2021 1.77x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 week 0
Extreme 1.0E-6
0
1 month 0
Extreme 1.0E-6
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
10 years 0
Extreme 1.0E-6
0.02
Manager TitleAgeSince
Chief Executive Officer - 04/03/2024
Chief Operating Officer 45 02/08/2021
Director TitleAgeSince
Chairman - 04/03/2024
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 8.77T
+4.82%-1.70%-9.41%+52.90% 705.47Cr
+2.17%+0.26%-7.12%-17.69% 400.35Cr
+3.10%+5.85%+29.09% - 269.66Cr
+2.12%+0.69%-11.89%-30.59% 154.14Cr
+0.86%-14.55%+61.51%+1,863.79% 134.75Cr
+2.64%-2.35%-19.39%-16.48% 129.73Cr
+0.99%-3.97%+96.12% - 101.76Cr
-0.52%+0.68%-29.16%-19.76% 81Cr
+1.40%+12.41%+3.76%+10.51% 80Cr
Average +1.78%-2.22%+12.61%+263.24% 205.66Cr
Weighted average by Cap. +2.97%-3.27%+4.87%+162.45%

Financials

2020 2021
Net sales 43.88L 38.02L 35.88L 32.55L 61.06L 42Cr 61.51L 4.29Cr 1.65Cr 21Cr 1.65Cr 1.61Cr 68Cr 58.97L 51.1L 48.22L 43.74L 82.06L 57Cr 82.65L 5.76Cr 2.22Cr 29Cr 2.21Cr 2.17Cr 91Cr
Net income 10L 9L 8L 7L 13.79L 9.5Cr 13.89L 96.75L 37.28L 4.82Cr 37.21L 36.39L 15Cr 2L 1L 1L 1L 2L 1.57Cr 2L 15.97L 6L 79.53L 6L 6L 2.53Cr
Net Debt 58.7L 50.86L 48L 43.55L 81.69L 56Cr 82.28L 5.73Cr 2.21Cr 29Cr 2.2Cr 2.16Cr 91Cr 59.29L 51.37L 48.48L 43.98L 82.51L 57Cr 83.11L 5.79Cr 2.23Cr 29Cr 2.23Cr 2.18Cr 92Cr
Logo RushNet, Inc.
RushNet, Inc. provides management and insurance billing services to clinical laboratories and laboratory services. The Company’s subsidiaries include Chattahoochee Physicians Laboratory Services, LLC, doing business as HeliosDx, and Grandeza Healthcare Consultants, LLC (Grandeza). HeliosDx offers urine drug testing, allergy droplet cards, oral fluids, Polymerase Chain Reaction (PCR) for nails, wounds, respiratory pathogens, sexually transmitted infections, gastrointestinal issues, urinary tract infections, and pharmacogenomics testing through lab partners. Grandeza provides management and insurance billing services to clinical reference laboratories.
Employees
18
Date Price Change Volume
11/26/11 $0.000001 0.00% 1,40,000
  1. Stock Market
  2. Stocks
  3. RSHN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!